March 5, 2021
Program is based on a minimum of 25% of time allowed for questions and answers.
| 8:30 – 8:45 am | Self-guided Orientation to Online Platform |
| 8:45 – 9:00 am | WELCOME & INTRODUCTIONS Dr. Shiva Jayaraman (Chair) Unity Health |
| 9:00 – 9:55 am | Update on HCC Management Dr. Ghassan Abou-Alfa Memorial Sloan Kettering |
| 10:00 – 10:55 am | Best Neoadjuvant Strategy for Resectable Pancreas Cancer Dr. Matthew Katz MD Anderson |
| 11:00 – 11:15 am | BREAK |
| 11:15am – 12:10 pm | Gastroesophageal and Gastric Cancer Management Dr. Yelena Y. Janjigian Memorial Sloan Kettering |
| 12:15 – 12:45 pm | Tumor Board: Painless Jaundice NYD Participants will be asked to use polling questions to choose answers in the case. Participants will be able to ask questions during case discussions. Moderator: Suneil Khanna Dr. Elena Elimova Dr. Shiva Jayaraman Dr. Chirag Patel Dr. Sylvia Ng Dr. Corwyn Rowsell Dr. Elaine Yeung |
| 12:50 – 1:30pm | Multidisciplinary Session: Oncology Biosimilar Implementation Practical Considerations for Cancer Clinics Moderator: Mark Pasetka, BSc, BScPharm, PharmD, RPh Flay Charbonneau, BSc Pharm, RPH Manager, Odette Cancer Centre Pharmacy Learning Objectives: 1. To articulate the principles behind biosimilar implementation. 2. To discuss the logistical challenges of introducing biosimilars to the cancer clinic. 3. To describe metrics that may be used to evaluate biosimilar implementation. |
| 1:30 – 1:40 pm | SUMMARY & CLOSING Dr. Shiva Jayaraman (Chair) |